关注
Jeremy Sharib MD
Jeremy Sharib MD
在 duke.edu 的电子邮件经过验证
标题
引用次数
引用次数
年份
Blockade of leukemia inhibitory factor as a therapeutic approach to KRAS driven pancreatic cancer
MT Wang, N Fer, J Galeas, EA Collisson, SE Kim, J Sharib, F McCormick
Nature communications 10 (1), 3055, 2019
912019
Three-dimensional radiologic assessment of chemotherapy response in Ewing sarcoma can be used to predict clinical outcome
M Aghighi, J Boe, J Rosenberg, R Von Eyben, RS Gawande, P Petit, ...
Radiology 280 (3), 905-915, 2016
502016
Phase I study of ixabepilone, mitoxantrone, and prednisone in patients with metastatic castration-resistant prostate cancer previously treated with docetaxel-based therapy: a …
JE Rosenberg, CJ Ryan, VK Weinberg, DC Smith, M Hussain, TM Beer, ...
Journal of clinical oncology 27 (17), 2772-2778, 2009
472009
Surgical overtreatment of pancreatic intraductal papillary mucinous neoplasms: Do the 2017 International Consensus Guidelines improve clinical decision making?
JM Sharib, AL Fonseca, DS Swords, K Jaradeh, PM Bracci, MA Firpo, ...
Surgery 164 (6), 1178-1184, 2018
462018
Global protease activity profiling provides differential diagnosis of pancreatic cysts
SL Ivry, JM Sharib, DA Dominguez, N Roy, SE Hatcher, MT Yip-Schneider, ...
Clinical Cancer Research 23 (16), 4865-4874, 2017
422017
Effect of the somatostatin analog octreotide acetate on circulating insulin-like growth factor-1 and related peptides in patients with non-metastatic castration-resistant …
TW Friedlander, VK Weinberg, EJ Small, J Sharib, AL Harzstark, AM Lin, ...
Urologic Oncology: Seminars and Original Investigations 30 (4), 408-414, 2012
322012
Theranostic targeting of CUB domain containing protein 1 (CDCP1) in pancreatic cancer
A Moroz, YH Wang, JM Sharib, J Wei, N Zhao, Y Huang, Z Chen, ...
Clinical Cancer Research 26 (14), 3608-3615, 2020
312020
Cost-effectiveness of consensus guideline based management of pancreatic cysts: The sensitivity and specificity required for guidelines to be cost-effective
J Sharib, L Esserman, EJ Koay, A Maitra, Y Shen, KS Kirkwood, ...
Surgery 168 (4), 601-609, 2020
282020
Ixabepilone, mitoxantrone, and prednisone for metastatic castration‐resistant prostate cancer after docetaxel‐based therapy: A phase 2 study of the department of defense …
AL Harzstark, JE Rosenberg, VK Weinberg, J Sharib, CJ Ryan, DC Smith, ...
Cancer 117 (11), 2419-2425, 2011
282011
Hepatic artery infusion pumps: a surgical toolkit for intraoperative decision-making and management of hepatic artery infusion-specific complications
JM Sharib, JM Creasy, B Wildman-Tobriner, C Kim, H Uronis, SD Hsu, ...
Annals of surgery 276 (6), 943-956, 2022
202022
The lysosomal aminopeptidase tripeptidyl peptidase 1 displays increased activity in malignant pancreatic cysts
SL Ivry, GM Knudsen, F Caiazza, JM Sharib, K Jaradeh, M Ravalin, ...
Biological Chemistry 400 (12), 1629-1638, 2019
202019
Predictors of acute chemotherapy‐associated toxicity in patients with Ewing sarcoma
JM Sharib, J Cyrus, A Horvai, FK Gray Hazard, J Neuhaus, KK Matthay, ...
Pediatric blood & cancer 59 (4), 611-616, 2012
182012
Comparison of Latino and non‐Latino patients with Ewing sarcoma
J Sharib, A Horvai, FK Gray Hazard, H Daldrup‐Link, R Goldsby, ...
Pediatric blood & cancer 61 (2), 233-237, 2014
122014
Ixabepilone, mitoxantrone, and prednisone in patients with metastatic castration-resistant prostate cancer refractory to docetaxel-based therapy: a phase II study of the DOD …
E Small, A Harzstark, VK Weinberg, DC Smith, P Mathew, T Beer, G Liu, ...
Journal of Clinical Oncology 27 (15_suppl), 5058-5058, 2009
112009
Combined primary resection with hepatic artery infusion pump implantation is safe for unresectable colorectal liver metastases
MC Turley, C Moore, JM Creasy, J Sharib, B Lan, JKM Thacker, J Migaly, ...
Journal of Gastrointestinal Surgery 26 (4), 764-771, 2022
62022
Incidence and Presenting Characteristics of Angiosarcoma in the US, 2001-2020
MJ Wagner, V Ravi, SK Schaub, EY Kim, J Sharib, H Mogal, M Park, ...
JAMA Network Open 7 (4), e246235-e246235, 2024
42024
Early and accurate diagnosis of pancreatic cancer?
J Sharib, K Kirkwood
Oncotarget 7 (52), 85676, 2016
42016
Second-line combination chemotherapy: A phase I study of ixabepilone, mitoxantrone, and prednisone in patients with metastatic hormone-refractory prostate cancer (HRPC …
AL Harzstark, VK Weinberg, J Sharib, DC Smith, MH Hussain, TM Beer, ...
Journal of Clinical Oncology 26 (15_suppl), 5151-5151, 2008
42008
Spatial Computation of the Immune and Stromal Characteristics of Biophysical Subtypes of Pancreatic Ductal Adenocarcinoma
J Sharib, M Zaid, A Dai, L Widman, S Behr, K Kirkwood, E Koay
Annals of Surgical Oncology 27 (SUPPL 1), S127-S128, 2020
32020
Concordance in Oncogenic Alterations Between the Primary Tumor and Advanced Disease: Insights Into the Heterogeneity of Intrahepatic Cholangiocarcinoma
SM McIntyre, WA Preston, H Walch, J Sharib, R Kundra, C Sigel, ...
JCO Precision Oncology 8, e2300534, 2024
22024
系统目前无法执行此操作,请稍后再试。
文章 1–20